Corcept Therapeutics Inc
CORT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001088856
In the last 90 days, Corcept Therapeutics Inc insiders filed 0 open-market purchases and 21 sales; 424 institutions reported holding it in 13F filings for Q2 2026, worth $7.15B in total; no superinvestor holds it.
Superinvestors holding CORT, Q2 2026
No superinvestor reported holding CORT in Q2 2026.
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of CORT each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q2 2023
0 superinvestors holding at quarter end
- Sold out
- Maverick Capital
Q1 2023
1 superinvestor holding at quarter end